Why the study?
Baroreflex sensitivity is associated with clinical outcome in aneurysmal subarachnoid haemorrhage, but few studies have investigated this in typical clinical settings.
Does outcome modeling using 'noisy data' perform as well as 'clean data' in predicting short-term outcomes after aneurysmal subarachnoid haemorrhage?
Observational
Yes
Does outcome modeling using 'noisy data' perform as well as 'clean data' in predicting short-term outcomes after aneurysmal subarachnoid haemorrhage?
Odds Ratio: 1.1 (95% CI 1.01–1.2)
p-value: p=<0.001
Early baroreflex sensitivity is independently associated with short-term outcome after aSAH, even when including patients on vasoactive medications ('noisy data').
BACKGROUND: Baroreflex sensitivity (BRS) is associated with clinical outcome in patients with aneurysmal subarachnoid haemorrhage (aSAH); however few studies have investigated this in typical clinical settings. This two-centre study evaluated how outcome models differ when excluding patients who received beta-blockers and/or noradrenaline ('clean data' set) versus including all of them ('noisy data' set). METHODS: This retrospective study included consecutive aSAH patients from Addenbrooke's Hospital (UK) and Wroclaw Medical University (Poland). Early BRS was measured using the cross-correlation method. A favorable outcome was defined as a Glasgow Outcome Scale (GOS) score of 4-5 at discharge. RESULTS: = 32.27; p < 0.001, AUC = 0.84) included BRS (OR 1.10, 95%CI [1.01,1.20]) and GCS (OR 1.32, 95%CI [1.16,1.51]). CONCLUSIONS: Early BRS was independently associated with short-term outcome after aSAH, regardless of beta-blockers or noradrenaline use. In the 'clean data' set, HR was significantly associated with outcome, whilst in the 'noisy data' set, BRS was significantly associated with outcome. A larger multicentre study is required to validate these findings.
No takes yet. Share an insight, caveat, or question.
Uryga et al. (2025) conducted an observational in Aneurysmal subarachnoid haemorrhage (aSAH). Early baroreflex sensitivity (BRS) in 'noisy data' (including beta-blocker/noradrenaline use) vs. 'clean data' (excluding beta-blocker/noradrenaline use) was evaluated on Favorable outcome (Glasgow Outcome Scale score of 4-5 at discharge) (OR 1.10, 95% CI 1.01-1.20, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: